SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Share this page:

Title

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Subject

Description

As the initial phase of the COVID-19 pandemic passes its peak in many countries, serological studies are becoming increasingly important in guiding public health responses. Antibody testing is crucial for monitoring the evolution of the pandemic, providing a more complete picture of the total number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than molecular diagnostic testing alone.

Go to the SeroTracker referenced in this article.

Date Last Updated (Year-Month-Day)

2020-08-04

Citation

Arora, Rahul K., Abel Joseph, Jordan Van Wyk, Simona Rocco, Austin Atmaja, Ewan May, Tingting Yan, Niklas Bobrovitz, Jonathan Chevrier, Matthew P. Cheng, Tyler Williamson, and David L. Buckeridge. 2020. "SeroTracker: a global SARS-CoV-2 seroprevalence dashboard." The Lancet Infectious Diseases.

Accessibility

Free online